- Report
- May 2021
- 50 Pages
China
From €2470EUR$2,600USD£2,125GBP
- Report
- April 2021
- 40 Pages
China
From €2470EUR$2,600USD£2,125GBP
- Newsletter
- May 2024
- 2 Pages
Global
From €124EUR$131USD£107GBP
- Report
- May 2018
- 47 Pages
Global
From €9500EUR$10,000USD£8,172GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£973GBP
- Report
- August 2022
United States
From €1843EUR$1,940USD£1,585GBP
- Report
- February 2021
Global
From €2812EUR$2,960USD£2,419GBP
- Report
- August 2021
Global
From €3791EUR$3,990USD£3,261GBP
- Report
- August 2021
Europe
From €3249EUR$3,420USD£2,795GBP
- Clinical Trials
- February 2022
- 1087 Pages
Global
From €2375EUR$2,500USD£2,043GBP
- Report
- November 2021
- 108 Pages
Global
From €10446EUR$10,995USD£8,986GBP
- Clinical Trials
- October 2021
- 999 Pages
Global
From €2375EUR$2,500USD£2,043GBP
- Report
- January 2023
- 1469 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- September 2021
- 34 Pages
Global
From €3795EUR$3,995USD£3,265GBP
- Report
- June 2018
- 30 Pages
Global
From €2375EUR$2,500USD£2,043GBP
- Drug Pipelines
- September 2020
- 956 Pages
Global
From €2375EUR$2,500USD£2,043GBP
- Report
- August 2022
- 100 Pages
Global
From €4555EUR$4,795USD£3,919GBP
- Report
- May 2022
- 40 Pages
Poland
From €2465EUR$2,595USD£2,121GBP
From €2465EUR$2,595USD£2,121GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €2465EUR$2,595USD£2,121GBP
The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more